0.350
0.01 (2.91%)
| Penutupan Terdahulu | 0.340 |
| Buka | 0.344 |
| Jumlah Dagangan | 585,662 |
| Purata Dagangan (3B) | 1,458,719 |
| Modal Pasaran | 20,728,294 |
| Harga / Buku (P/B) | 0.460 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 2 May 2025 - 5 May 2025 |
| EPS Cair (TTM) | -0.810 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 66.87% |
| Nisbah Semasa (MRQ) | 19.40 |
| Aliran Tunai Operasi (OCF TTM) | -39.50 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -22.38 M |
| Pulangan Atas Aset (ROA TTM) | -29.86% |
| Pulangan Atas Ekuiti (ROE TTM) | -78.32% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Elevation Oncology, Inc. | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 1.5 |
| Osilator Teknikal | 0.0 |
| Purata | -0.17 |
|
Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs. Its product candidate, EO-3021 (also known as SYSA1801 or CPO102), is an ADC comprised of a fully human anti-Claudin 18.2 immunoglobulin G1 (IgG1) monoclonal antibody (mAb) site-specifically conjugated with a cleavable linker to the cytotoxic monomethyl auristatin E (MMAE) payload. Claudin 18.2 is overexpressed in several types of cancers, including gastric, esophageal, pancreatic, ovarian and lungon. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 0.36% |
| % Dimiliki oleh Institusi | 57.31% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |